Pharmaceutical

TheracosBio and BAMCO to bring BRENZAVVY to sub-Saharan Africa for T2D

TheracosBio has entered a partnership with BAMCO Africa to deliver BRENZAVVY (bexagliflozin) to patients in sub-Saharan Africa.

Oct 20, 2024 - 04:00
TheracosBio and BAMCO to bring BRENZAVVY to sub-Saharan Africa for T2D
TheracosBio has entered a partnership with BAMCO Africa to deliver BRENZAVVY (bexagliflozin) to patients in sub-Saharan Africa.
Read the original article

Tags:

Previous Article

mRNA licensing agreements surge 800% amid GSK lawsuits

Next Article

Unresolved clawback issues obstruct Greece’s potential pharmaceutical framework ...

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

As England’s virus hospitalisations surge flu vaccines evolve

As England’s virus hospitalisations surge flu vaccines ...

Feb 2, 2024

CohBar and Morphogenesis in merger for immuno-oncology therapies

CohBar and Morphogenesis in merger for immuno-oncology ...

May 24, 2023

FDA approves import of French drug for syphilis amidst wider drug shortages

FDA approves import of French drug for syphilis amidst ...

Jan 11, 2024